Shareholders' equity · 2011–2025
Neogenomics shareholders' equity
$837M−7.3% · FY2025
Neogenomics (NEO) reported $837M in shareholders' equity for fiscal 2025, −7.3% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $837M | −7.3% | Open → |
| FY20242024-12-31 | $902M | −4.2% | Open → |
| FY20232023-12-31 | $942M | −5.7% | Open → |
| FY20222022-12-31 | $998M | −9.9% | Open → |
| FY20212021-12-31 | $1.1B | +59.6% | Open → |
| FY20202020-12-31 | $694M | +36.8% | Open → |
| FY20192019-12-31 | $507M | +58.3% | Open → |
| FY20182018-12-31 | $320M | +86.3% | Open → |
| FY20172017-12-31 | $172M | +5.9% | Open → |
| FY20162016-12-31 | $162M | −22.2% | Open → |
| FY20152015-12-31 | $209M | +245.2% | Open → |
| FY20142014-12-31 | $60.4M | +178.2% | Open → |
| FY20132013-12-31 | $21.7M | +135.6% | Open → |
| FY20122012-12-31 | $9.2M | +56.3% | Open → |
| FY20112011-12-31 | $5.9M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +42.5%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neogenomics shareholders' equity |url=https://companiesranked.com/en/company/neogenomics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neogenomics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/neogenomics/shareholders-equityBibTeX
@misc{companiesranked-en-company-neogenomics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Neogenomics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neogenomics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001077183-26-000059 · July 28, 2026
{{cite web |title=Neogenomics shareholders' equity — 10-Q (0001077183-26-000059) |url=https://www.sec.gov/Archives/edgar/data/1077183/000107718326000059/neo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-28}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.